documents: FDA-2025-N-2787-0007

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2025-N-2787-0007 FDA FDA-2025-N-2787 Biosimilar User Fee Act III Future Needs in the Development of Interchangeable Products Post-Workshop; Draft Strategy Document Notice Notice of Availability 2026-09-18T04:00:00Z 2026 9 2026-09-18T04:00:00Z 2026-11-18T04:59:59Z 2026-09-18T18:37:52Z 2026-19166 1 0 09000064b958ecea

Links from other tables